Výpis publikací

HOLZEROVÁ, Milena, Edgar FABER, Jitka VESELOVSKÁ, Helena URBÁNKOVÁ, Jana BALCÁRKOVÁ, Šárka ROŽMANOVÁ, Jaroslava VOGLOVÁ, Jan MUŽÍK, Karel CHROUST, Karel INDRÁK a Marie JAROŠOVÁ. Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results. Cancer Genetics and Cytogenetics. 2009, roč. 191, č. 1, s. 1-9. ISSN 0165-4608.

ŠIMARA, Pavel, Steven GRANT, Tessa HOLYOAKE a Francesca PELLICANO. MEK inhibition enhances BMS-214662-induced apoptosis in primitive CD34+ CML stem/progenitor cells. In ESH: CHRONIC MYELOID LEUKEMIA - Biological Basis of Therapy. 2009.

JURČEK, T., Dana DVOŘÁKOVÁ, J. POSPÍŠILOVÁ, D. OHLÍDALOVÁ a Jiří MAYER. An atypical junction of BCR-ABL gene as molelcular marker for quantitative monitoring of minimal residual disease in patients with chronic myeloid leukemia (CML). 2008.

FABER, Edgar, Jan MUŽÍK, Vladimír KOZA, Eva DEMEČKOVÁ, Jaroslava VOGLOVÁ, Ludmila DEMITROVIČOVÁ, Juraj CHUDEJ, Imrich MARKULJAK, Eduard CMUNT, Tomáš KOZÁK, Elena TOTHOVÁ, Marie JAROŠOVÁ, Ladislav DUŠEK a Karel INDRÁK. COMPARISON OF ALLOGENEIC STEM CELL TRANSPLANTATION AND IMATINIB FOR CHRONIC MYELOID LEUKEMIA: RESULTS FROM CAMELIA REGISTRY. In 13th Congress of the European-Hematology-Association. 2008.

BRYCHTOVÁ, Y., Marta KREJČÍ, Michael DOUBEK, Dana DVOŘÁKOVÁ, O. HORKÝ, Jiří MAYER a Jiří VORLÍČEK. Long-term results of reduced-intensity allogeneic hematopoietic stem cell transplantation for 1ST chronic phase CML. 2008.

VOGLOVÁ, Jaroslava, Jan MUŽÍK, Kateřina STEINEROVÁ, Ludmila DEMITROVIČOVÁ, Edgar FABER, Michael DOUBEK, Hana KLAMOVÁ, L. NOVÁKOVÁ, Elena TOTHOVÁ, Zuzana SNINSKÁ a Karel INDRÁK. RESPONSE OF SECONDARY CHRONIC MYELOID LEUKEMIA TO IMATINIB. COOPERATIVE STUDY OF CML REGISTRIES. In 13th Congress of the European-Hematology-Association. 2008.

FAJKUSOVÁ, Lenka, Jiří FAJKUS, Klára POLÁČKOVÁ, Jaroslav FULNEČEK, Dana DVOŘÁKOVÁ a Eva KRAHULCOVÁ. Detailed Mapping of Methylcythosine Positions at the CpG Island Surrounding tha Pa Promoter at the bcr-abl Locus in CML Patients in Two Cell Lines, K562 and BV 173. Blood Cells, Molecules and Diseases. Orlando, Florida: Academic Press, 2000, roč. 26, č. 3, s. 193-204. ISSN 1079-9796.

KOZUBEK, Stanislav, Emilie LUKÁŠOVÁ, Andrea MAREČKOVÁ, Magdalena SKALNÍKOVÁ, Michal KOZUBEK, Eva BÁRTOVÁ, Václav KROHA, Eva KRAHULCOVÁ a Jana ŠLOTOVÁ. The topological organization of chromosomes 9 and 22 in cell nuclei has a determinative role in the induction of t(9,22) translocations and in the pathogenesis of t(9,22) leukemias. Chromosoma. Berlin: Springer-Verlag, 1999, roč. 108, č. 7, s. 426-435. ISSN 0009-5915.

LUKÁŠOVÁ, Emilie, Stanislav KOZUBEK, Michal KOZUBEK, Jana KJERONSKÁ, Leonard RÝZNAR, Jana HORÁKOVÁ, Eva KRAHULCOVÁ a Gerda HORNECK. Localisation and distance between ABL and BCR genes in interphase nuclei of bone marrow cells of control donors and patients with chronic myeloid leukemia. Human Genetics. 1997, roč. 100, 5/6, s. 525-535. ISSN 0340-6717.